Genome & Company Joins Lilly TuneLab, Advancing AI-Based New Drug Development
Predicted impact: Low
Partnership with Lilly TuneLab for AI drug development; no deal value disclosed.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.